Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581

Am J Surg. 2022 Jul;224(1 Pt B):459-464. doi: 10.1016/j.amjsurg.2022.01.017. Epub 2022 Jan 22.

Abstract

Background: Relapse of early-stage colon cancer (CC) after curative-intent resection occurs. We hypothesized that known risk factors for peritoneal metastases (PM) can define a high-risk state (HRS) that predicts recurrence and mortality.

Methods: CALGB9581 trial patients receiving no adjuvant treatment after stage-II CC resection were included. Positive radial margins, T4 invasion, obstruction/perforation or lymphovascular invasion defined the HRS. Cox proportional hazard models determined association with overall (OS) and disease-free survival (DFS).

Results: Median follow-up in 873 included patients was 8.1 years. Five-year OS was 85.8%. HRS+ patients had lower 5-year DFS (68.7 vs. 82.4%, P = 0.003) and OS (75.5 vs. 87.8%, P = 0.001). HRS+ was independently predictive of worse DFS and OS (HR 1.52 and 1.64, P < 0.01). Among recurrences, HRS+ patients showed shorter median OS (3.3 vs. 5.3 years, P = 0.01).

Conclusions: HRS criteria identify a cohort of CC patients at high-risk of recurrence and death. Studies of novel surveillance techniques in such patients are warranted.

Keywords: Colon cancer; Outcomes; Peritoneal metastases; Risk assessment; Stage-II; Survival.

Publication types

  • Clinical Trial

MeSH terms

  • Chemotherapy, Adjuvant
  • Colonic Neoplasms* / pathology
  • Colonic Neoplasms* / surgery
  • Disease-Free Survival
  • Humans
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Staging
  • Peritoneal Neoplasms* / pathology
  • Peritoneal Neoplasms* / surgery
  • Prognosis
  • Proportional Hazards Models